Studies Investigate Whether Antivirals Like Paxlovid May Prevent Long COVID

This study, published in JAMA, investigates whether antiviral treatments like Paxlovid (nirmatrelvir combined with ritonavir) and Lagevrio (molnupiravir) might prevent Long COVID. Long COVID is defined by the U.S. government as health issues that continue or develop 4 weeks or more after an initial SARS-CoV-2 infection. Key Highlights: This summary provides an overview of the study’s key findings and implications, crucial for understanding the potential role of antiviral treatments in preventing Long COVID. Read More: